Additionally, the expression levels of VEGF and pVEGFR2 in tumour tissues were downregulated following apatinib treatment, suggesting that apatinib inhibited the expression of VEGF and pVEGFR2 in SCLC tumours. Here, VEGFA is linked to neoplasm.